Email this article 
Post a Comment 
Hide
Show all
Influence of in-feed oxolinic acid therapy on the brain histoarchitecture and virulence factors of Streptococcus agalactiae infecting Nile tilapia Oreochromis niloticus
Abstract
Streptococcosis and its management are major constraints to tilapia aquaculture. The present study assessed the effect of oral administration of 12 mg oxolinic acid (OA)/kg fish/day for 7 uninterrupted days against Streptococcus agalactiae LCR1 (Sa) infection and its influence on histopathological anomalies in the forebrain, optic tectum region of the mid-brain and granular cell layer of the cerebellum of Oreochromis niloticus. Besides, attempts were made to understand how the OA impacts the glycosyltransferases and CAMP factor of S. agalactiae through molecular docking. The LD₅₀ of Sa was 1.26 × 10⁸ cells/fish. Sa infection was apparent in OA-treated and untreated groups, and the brain tissues exhibited the progression and reversal of meningitis. The forebrain exhibited thickening of the meninx primitiva, vacuolation, and degeneration in the brain parenchyma and meninx primitiva. Inflammatory changes such as meningitis and mononuclear cell infiltration were documented. The midbrain had edematous optic tectum, loosening of connective tissue, and leukocyte infiltration. In the granular cell layer, cerebellum changes such as spongiform encephalopathy and necrosis indicate region-specific damage. However, the OA effectively reduced the severity of brain tissue damage, possibly by its binding affinities and upsetting the activities of glycosyltransferases and CAMP factor, as confirmed by molecular docking. These results confirmed that OA can cross the blood-brain barrier and interact with virulence proteins to reduce the Sa infection in the brain. Furthermore, the results underscore its responsible use in aquaculture, as OA is a critically important human medicine and ought to be used as a secondary treatment.
Keywords
Full Text:
View Full TextReferences
FAO. The State of World Fisheries and Aquaculture 2024 Blue Transformation in Action. Rome: Food and Agriculture Organization of the United Nations; 2024. Available from: https://doi.org/10.4060/cd0683en.
El-Sayed AFM. Tilapia Culture. 2nd ed. London: Academic Press; 2019. Available from: https://doi.org/10.1079/9780851990149.0000.
Haenen OL, Dong HT, Hoai TD, Crumlish M, Karunasagar I, Barkham T, et al. Bacterial diseases of tilapia, their zoonotic potential and risk of antimicrobial resistance. Reviews in Aquaculture. 2023;15:154-85. Available from: https://doi.org/10.1111/raq.12743.
Zhang Z. Research advances on tilapia streptococcosis. Pathogens. 2021;10(5):550-8. Available from: https://doi.org/10.3390/pathogens10050558.
Adikesavalu H, Banerjee S, Patra A, Abraham TJ. Meningoencephalitis in farmed monosex Nile tilapia (Oreochromis niloticus L.) caused by Streptococcus agalactiae. Fisheries and Aquatic Life. 2017;5(3):187-200. Available from: https://doi.org/10.1515/aopf-2017-0018.
Eto SF, Fernandes DC, de Moraes AC, da Costa-Alecrim JV, de Souza PG, de Carvalho FCA, et al. Meningitis caused by Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus): infection and inflammatory response. Animals. 2020;10:2166. Available from: https://doi.org/10.3390/ani10112166.
Syuhada RM, Zamri-Saad MY, Ina-Salwany M, Mustafa NN, Nasruddin MNM, Desa SA, et al. Molecular characterization and pathogenicity of Streptococcus agalactiae serotypes Ia ST7 and III ST283 isolated from cultured red hybrid tilapia in Malaysia. Aquaculture. 2020;515:734543. Available from: https://doi.org/10.1016/j.aquaculture.2019.734543.
Cao JZ, Liu D, Zhang F, Guo F, Gao M, Wang M, et al. Distribution and localization of Streptococcus agalactiae in different tissues of artificially infected tilapia (Oreochromis niloticus). Aquaculture. 2022;546:737370. Available from: https://doi.org/10.1016/j.aquaculture.2021.737370.
Palang I, Withyachumnarnkul B, Senapin S, Sirimanapong W, Vanichviriyakit R. Brain histopathology in red tilapia Oreochromis sp. experimentally infected with Streptococcus agalactiae serotype III. Microscopy Research and Technique. 2020;83(8):877-88. Available from: https://doi.org/10.1002/jemt.23481.
World Health Organization (WHO). Critically Important Antimicrobials for Human Medicine, 6th Revision. Geneva; 2019. Accessed: 2025-10-12. Available from: https://www.who.int/publications/i/item/9789241515528.
Lulijwa R, Rupia EJ, Alfaro AC. Antibiotic use in aquaculture, policies and regulation, health and environmental risks: A review of the top 15 major producers. Reviews in Aquaculture. 2020;12:640-63. Available from: https://doi.org/10.1111/raq.12344.
Schar D, Klein EY, Laxminarayan R, Gilbert M, Van Boeckel TP. Global trends in antimicrobial use in aquaculture. Scientific Reports. 2020;10:21878. Available from: https://doi.org/10.1038/s41598-020-78849-3.
World Organisation for Animal Health (WOAH). Annual Report on Antimicrobial Agents Intended for Use in Animals, 8th Report. Paris; 2024. 44 p, Accessed: 2025-10-12. Available from: https://doi.org/10.20506/amu.3474.
United States Food and Drug Administration (USFDA). Approved Aquaculture Drugs. Silver Spring, MD; 2024. Accessed: 2023-03-13. Available from: https://www.fda.gov/animal-veterinary/aquaculture/approved-aquaculture-drugs.
World Health Organization (WHO). List of Medically Important Antimicrobials. Geneva; 2024. Accessed: 2025-10-12. Available from: https://cdn.who.int/media/docs/default-source/gcp/who-mia-list-2024-lv.pdf.
EMEA. Committee for Medicinal Products for Veterinary Use: Oxolinic Acid (Extension to All Food-Producing Species). Lon-don; 2005. Available from: https://www.ema.europa.eu/en/documents/committee-report/committee-medicinal-products-veterinary-use-cvmp-monthly-report-application-procedures-guidelines_en-4.pdf.
OIE, List of Antimicrobial Agents of Veterinary Importance, Office International des Epizooties (World Organization for Animal Health). Paris; 2019. Accessed: 2025-10-12. Available from: https://www.woah.org/app/uploads/2021/03/a-oie-list-antimicrobials-july2019.pdf.
World Organisation for Animal Health (OIE). Guidelines and Resolutions on Antimicrobial Resistance and the Use of Antimicrobial Agents. Paris; 2020. Accessed: 2025-10-12. Available from: https://www.oie.int/fileadmin/Home/eng/.
Love DC, Fry JP, Cabello F, Good CM, Lunestad BT. Veterinary drug use in United States net-pen salmon aquaculture: Implications for drug use policy. Aquaculture. 2020;518:734820. Available from: https://doi.org/10.1016/j.aquaculture.2019.734820.
Rigos G, Kogiannou D, Padrós F, Cristofol C, Florio D, Fioravanti M, et al. Best therapeutic practices for the use of antibacterial agents in finfish aquaculture: A particular view on European seabass (Dicentrarchus labrax) and gilthead seabream (Sparus aurata) in Mediterranean aquaculture. Reviews in Aquaculture. 2021;13:1285-323. Available from: https://doi.org/10.1111/raq.12523.
Patel JB, Abraham TJ, Bardhan A, Das R, Sen A, Boda S, et al. Efficacy of oxolinic acid against Aeromonas hydrophila infection in Nile tilapia (Oreochromis niloticus) juveniles. Aquaculture Studies. 2024;24(3):AQUAST1653.
Sinha P, Abraham TJ, Sen A, Sharon J, Das R, Ghorai A, et al. Oxolinic acid therapy: An effective way to reduce Aeromonas veronii infection in Oreochromis niloticus and improve biochemical and hematological parameters and histopathological lesions. Fisheries and Aquatic Life. 2025;33:1-18. Available from: https://doi.org/10.2478/aopf-2025-0001.
Abraham TJ, Patel JB, Bardhan A, Rajisha R, Panda SK, Patil PK. Safety, tolerability, and biological responses of Oreochromis niloticus juveniles upon oral oxolinic acid administration. Journal of Veterinary Pharmacology and Therapeutics. 2024;47(2):121-33. Available from: https://doi.org/10.1111/jvp.13408.
Abdallah ESH, Metwally WGM, Abdel-Rahman MAM, Albano M, Mahmoud MM. Streptococcus agalactiae infection in Nile tilapia (Oreochromis niloticus): A review. Biology. 2024;13:914. Available from: https://doi.org/10.3390/biology13110914.
Wataradee S, Boonserm T, Samngamnim S, Ajariyakhajorn K. Characterization of virulence factors and antimicrobial susceptibility of Streptococcus agalactiae associated with bovine mastitis cases in Thailand. Animals. 2024;14:447. Available from: https://doi.org/10.3390/ani14030447.
Seifert KN, Adderson EE, Whiting AA, Bohnsack JF, Crowley PJ, Brady LJ. A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae. Microbiology. 2006;152(4):1029-40. Available from: https://doi.org/10.1099/mic.0.28516-0.
Gori A, Harrison OB, Mlia E, Nishihara Y, Chan JM, Msefula J, et al. Pan-GWAS of Streptococcus agalactiae highlights lineage-specific genes associated with virulence and niche adaptation. mBio. 2020;11(3):e00728-0. Available from: https://doi.org/10.1128/mBio.00728-20.
Rajagopal L. Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiology. 2009;4(2):201-21. Available from: https://doi.org/10.2217/17460913.4.2.201.
Julinta RB, Abraham TJ, Roy A, Singha J, Dash G, Nagesh TS, et al. Histopathology and wound healing in oxytetracycline treated Oreochromis niloticus (L.) against Aeromonas hydrophila intramuscular challenge. Journal of Aquaculture Research & Development. 2017;8:488. Available from: https://doi.org/10.4172/2155-9546.1000488.
Abraham TJ, Namdeo MS, Adikesavalu H, Banerjee S. Pathogenicity and pathology of Streptococcus agalactiae in challenged Mozambique tilapia Oreochromis mossambicus (Peters 1852) juveniles. Aquatic Research. 2019;2(4):182-90. Available from: https://doi.org/10.3153/AR19017.
Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology. 1938;27(3):493-7. Available from: https://www.cabidigitallibrary.org/doi/full/10.5555/19412202800.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. M100-s22 ed. Wayne, Pennsylvania, USA: CLSI; 2012.
Roberts RJ. Fish Pathology. 4th ed. John Wiley & Sons; 2012.
Bernet D, Schmidt H, Meier W, Burkhardt-Holm P, Wahli T. Histopathology in fish: proposal for a protocol to assess aquatic pollution. Journal of Fish Diseases. 1999;22(1):25-34. Available from: https://doi.org/10.1046/j.1365-2761.1999.00134.x.
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. Journal of Computational Chemistry. 2009;30(16):2785-91. Available from: https://doi.org/10.1002/jcc.21256.
Jeffrey GA. An Introduction to Hydrogen Bonding. Oxford University Press; 1997.
Santos Y, Toranzo AE, Barja JL, Nieto TP, Villa TG. Virulence properties and enterotoxin production of Aeromonas strains isolated from fish. Infection and Immunity. 1988;56:3285-93. Available from: https://doi.org/10.1128/iai.56.12.3285-3293.1988.
Kayansamruaj P, Pirarat N, Katagiri T, Hirono I, Rodkhum C. Molecular characterization and virulence gene profiling of pathogenic Streptococcus agalactiae populations from tilapia (Oreochromis sp.) farms in Thailand. Journal of Veterinary Diagnostic Investigation. 2014;26(4):488-95. Available from: https://doi.org/10.1177/1040638714534237.
Li S, Li Q, Liang J, Cao H, Li Z, Li A. Characterization and virulence of Streptococcus agalactiae deficient in SaeRS of the two-component system. Frontiers in Microbiology. 2023;14:1121621. Available from: https://doi.org/10.3389/fmicb.2023.1121621.
Uematsu K, Baba Y, Kake Y, Ikenaga T, Moon SJ, Miyai Y, et al. Central mechanisms underlying fish swimming. Brain, Behavior and Evolution. 2007;69(2):142-50. Available from: https://doi.org/10.1159/000095203.
Le Guennec L, Coureuil M, Nassif X, Bourdoulous S. Strategies used by bacterial pathogens to cross the bloodbrain barrier. Cellular Microbiology. 2020;22(1):e13132.
Su YL, Feng J, Li YW, Bai JS, Li AX. Development of a quantitative PCR assay for monitoring Streptococcus agalactiae colonization and tissue tropism in experimentally infected tilapia. Journal of Fish Diseases. 2016;39(2):229-38.
Isiaku AI, Sabri MY, Ina-Salwany MY, Hassan MD, Tanko PN, Bello MB. Biofilm is associated with chronic streptococcal meningoencephalitis in fish. Microbial Pathogenesis. 2017;102:59-68.
Guo CM, Chen RR, Kalhoro DH, Wang ZF, Liu GJ, Lu CP, et al. Identification of genes preferentially expressed by highly virulent piscine Streptococcus agalactiae upon interaction with macrophages. PLoS One. 2014;9(2):e87980.
Baldissera MD, Souza CF, Parmeggiani BS, Santos RC, Leipnitz G, Moreira KL, et al. Streptococcus agalactiae impairs cerebral bioenergetics in experimentally infected silver catfish. Microbial Pathogenesis. 2017;111:28-32.
de Sousa EL, Assane IM, Santos-Filho NA, Cilli EM, de Jesus RB, Pilarski F. Haematological, biochemical, and immunological biomarkers, antibacterial activity, and survival in Nile tilapia Oreochromis niloticus after treatment using antimicrobial peptide LL-37 against Streptococcus agalactiae. Aquaculture. 2021;533:736181.
Barichello T, Lemos JC, Generoso JS, Cipriano AL, Milioli GL, Marcelino DM, et al. Oxidative stress, cytokine/chemokine and disruption of blood-brain barrier in neonate rats after meningitis by Streptococcus agalactiae. Neurochemical Research. 2011;36:1922-30.
Van Doan H, Soltani M, Leitão A, Shafiei S, Asadi S, Lymbery AJ, et al. Streptococcosis: a re-emerging disease in aquaculture: significance and phytotherapy. Animals. 2022;12:2443.
Ghetas H, Neiana A, Khalil R, Khallaf M. Streptococcus agalactiae isolation and characterization in Nile tilapia (Oreochromis niloticus) with histopathological studies. Journal of Current Veterinary Research. 2021;3(1):70-9.
Vinarukwong N, Lukkana M, Berntsen JO, Wongtavatchai J. Therapeutic use of sulfadimethoxine-ormetoprim for control of Streptococcus agalactiae infection in Nile tilapia (Oreochromis niloticus) fry. Thai Journal of Veterinary Medicine. 2018;48(3):367-73.
Bowker JD, Ostland D, Bowman MP. Effectiveness of Aquaflor (50% florfenicol) to control mortality associated with Streptococcus iniae in freshwater-reared subadult sunshine bass. Journal of Aquatic Animal Health. 2010;22(4):254-65.
Zahari NIN, Rahman EA, Irekeola AA, Ahmed N, Rabaan AA, Alotaibi J, et al. A review of the resistance mechanisms for lactams, macrolides and fluoroquinolones among Streptococcus pneumoniae. Medicina. 2023;59(11):1927.
Hensler ME, Quach D, Hsieh CJ, Doran KS, Nizet V. CAMP factor is not essential for systemic virulence of Group B Streptococcus. Microbial Pathogenesis. 2008;44(1):84-8.
DOI: https://doi.org/10.36462/H.BioSci.202509
Refbacks
- There are currently no refbacks.
Copyright (c) 2025 Sinha P et al..
This work is licensed under a Creative Commons Attribution 4.0 International License.
...........................................................................................................................................................
Other "Highlights in" Journals
Highlights in Bioinformatics, Highlights in Chemistry, Highlights in Science, Highlights in Microbiology, Highlights in Plant Science
........................................................................................................................................
International Library of Science "HighlightsIn" is an Open Access Scientific Publishers, aiming to science and knowledge support